Latest Articles
Buy Rating Reaffirmed for Acrivon Therapeutics Amid Promising Endometrial Cancer Data and Strong Financial Position - TipRanks
Buy Rating Reaffirmed for Acrivon Therapeutics Amid Promising Endometrial Cancer Data and Strong Financial Position TipRanks
Published: April 1, 2025, 6:54 p.m.
Cervical cancer: Prevention through awareness, screening - Northside Hospital
Cervical cancer: Prevention through awareness, screening Northside Hospital
Published: April 1, 2025, 3:28 p.m.
Excess heme orchestrates progesterone resistance in uterine endometrial cancer through macrophage polarization and the IL-33/PAX8/PGR axis - ScienceDirect.com
Excess heme orchestrates progesterone resistance in uterine endometrial cancer through macrophage polarization and the IL-33/PAX8/PGR axis ScienceDirect.com
Published: April 1, 2025, 2:47 p.m.
Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR - Nature
Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR Nature
Published: April 1, 2025, 1:15 p.m.
Health experts push for campaign to curb diabetes, cancer in young adults - standardmedia.co.ke
Health experts push for campaign to curb diabetes, cancer in young adults standardmedia.co.ke
Published: April 1, 2025, 8:07 a.m.
Curcumin-gold nanoshell mediated near-infrared irradiation on human ovarian cancer cell: in vitro study.
Ovarian cancer is considered a predominant female reproductive malignancy and poses a significant threat due to its 80-90% fatality rate. The typical approach involves surgery and chemotherapy, which due to …
Published: April 1, 2025, midnight
Dr Lee on Responses With Nivolumab in Resectable dMMR Endometrial Cancer - OncLive
Dr Lee on Responses With Nivolumab in Resectable dMMR Endometrial Cancer OncLive
Published: March 31, 2025, 10:21 p.m.
CD8+ T Cell Activation in Endometrial Cancer: Prognostic Implications and Potential for - Frontiers
CD8+ T Cell Activation in Endometrial Cancer: Prognostic Implications and Potential for Frontiers
Published: March 31, 2025, 7:23 p.m.
Optimizing Management Strategies for Advanced Endometrial Cancer Progression After IO-Chemo - OncLive
Optimizing Management Strategies for Advanced Endometrial Cancer Progression After IO-Chemo OncLive
Published: March 31, 2025, 2:14 p.m.
Overview of Current Treatment Landscape of Advanced Endometrial Cancer - OncLive
Overview of Current Treatment Landscape of Advanced Endometrial Cancer OncLive
Published: March 31, 2025, 2:03 p.m.
Link copied to clipboard!